An oncolytic adenovirus to potentiate immune checkpoint inhibitor therapy against renal cell carcinoma
Cancer Approximately 90% of all kidney cancers involve renal cell carcinoma, against which researchers are racing to find more effective therapies. One of the major challenges in treating this and other cancers is ensuring that the immune cells that …